Epilepsy in Children and Youth: Advanced Program

Young husband and wife with their young daughter of 3 years-old

This series builds on the foundational curriculum and aims to develop proficiency in the management of epilepsy.

MARCH 4 - MAY 6, 2024 | 12:00 PM - 1:00 PM EST | WEEKLY


This program explores a range of complex topics such as drug resistant epilepsy, polypharmacy, genetics, ketogenic diet, and more. This program is intended for clinicians who are seeking to further their competencies in epileptology.

  • Next Session

    May 30, 2024

    12:00 pm 1:00 pm

    S2. Genetics 101:​ A Primer for Epilepsy Genetics

Case Support - supporting you and your patient graphic

Case Support

Healthcare providers can present your de-identified case for advice, support and written recommendations.

Submit a Case

This Quick Study series is facilitated by The Hospital for Sick Children.

The Hospital for Sick Children (SickKids) Logo


This Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by Continuing Professional Development, Faculty of Medicine, University of Toronto for up for up to 1.0 Mainpro+ credits.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Faculty of Medicine, University of Toronto. You may claim a maximum of 1.0 hours.

  • Identify evidence-supported indications and dosing
  • Recognize common drug-drug interactions and side effects
  • Recognize epilepsy can be a genetic condition
  • Identify patients with epilepsy that may benefit from genetic testing
  • Describe the process of genetic testing for epilepsy in Ontario
  • Describe the underlying mechanism of the ketogenic diet
  • Identify how the diet is monitored in children with epilepsy
  • Recognize clinical considerations for ketogenic diet as a treatment option for children living with epilepsy
  • Identify the evidence-supported indications and dosing for cannabinoid therapy in epilepsy
  • Recognize common drug-drug interactions, side effects, and practical considerations in using cannabinoids in pediatric epilepsy
  • Describe the ways in which healthcare professionals can support and facilitate families in accessing medical cannabis
  • Identify drug resistant epilepsy (DRE)
  • Recognize when to refer to a paediatric epilepsy program, referral pathways available in Ontario
  • Describe the importance of counseling regarding DRE
  • Recognize issues that may arise as children with epilepsy become teenagers including contraception and pregnancy, driving, and mood disorders
  • Identify the risk factors for SUDEP, current preventative measures, and the importance of counselling patients and families
  • Recognize factors impacting health care transition for youth with epilepsy
  • Identify the most common psychiatry and somatic co-morbidities associated to epilepsy
  • Discuss the management of the common psychiatric and somatic co-morbidities associated with epilepsy

Didactics & Recordings

You must be logged in to view this content.

Coming Soon

You must be logged in to view this content.

Clinical Leads

Dr. Lauren Sham

Dr. Lauren Sham, Paediatric Neurologist and Epileptologist

Medical Lead, SickKids

Dr. Elizabeth Donner

Dr. Elizabeth Donner, Paediatric Neurologist and Epileptologist

Medical Co-Lead, SickKids

Dr. Elizabeth Kerr

Dr. Elizabeth Kerr Neuropsychologist


Heather Oliveri, Social Worker


Female icon

Laura Wang, Clinical Pharmacist


David Carlone, Child and Adolescent Psychiatrist


Elana Ellison

Elana Ellison, Epilepsy Community Support

Epilepsy Toronto

Eden Peters

Eden Peters, Coordinator, Children and Youth Services

Epilepsy Toronto